results found
The coronavirus pandemic has resulted in millions of cases across the globe. The United States has one of the highest death rates due to COVID-19 across the world, and its mortality rates will likely increase. Due to different approaches to …
This chart collection looks at the availability of hospital resources and healthcare professionals in the United States and similarly wealthy countries. A related chart collection examines how the U.S.’s healthcare resources factor into the nation’s preparedness for the coronavirus pandemic.…
The coronavirus pandemic and subsequent public health response have led to extraordinary job loss in the United States. From February through May 2020, overall employment decreased 13% as roughly 20 million people lost work.
This chart collection examines where changes …
The ongoing novel coronavirus pandemic has already overwhelmed the health systems of several countries and is projected to overburden the health system in the United States. A surge in patients with the new coronavirus disease (COVID-19) would challenge …
Back in 1980, life expectancy at birth in the U.S. was similar to that of comparable countries. However, since then, the U.S. has gained just 4.9 years of life expectancy, while comparable countries have gained 7.8 years on average. This …
This chart collection explores the ways health spending has changed over time and projections of health spending in the future. An earlier brief also explored trends in this topic. …
In this collection of charts, we use a variety of data sources to explore trends in health outcomes, quality of care, and spending on treatment for people in the U.S. with diabetes and other endocrine disorders. In the U.S., diabetes …
Infant mortality (the death of an infant within the first year of life) is a widely-reported indicator of population health. This chart collection highlights key infant mortality trends and demographic variation within the United States and also explores infant mortality …
Prescription drug costs are a pressing concern for both consumers and policymakers. Rising drug prices affect patients’ out-of-pocket costs as well as the budgets of private and public payers, though the challenges vary by payer. This analysis compares prescription drug …
How can we know if the performance of the health system overall in the U.S. is good and if it is getting better or worse over time? This collection of charts explores trends in quality metrics in the United States …